Skip to main content
. 2021 Oct 26;11:751183. doi: 10.3389/fonc.2021.751183

Table 3.

Applications of NK cells in glioma.

Targets NK Source CAR construct Tumors Phase Reference/NCT
EGFRvIII NK92 cell line scFv-CD28TM+IC-CD3ζ Glioblastoma / Genßler et al. (118)
EGFRvIII YTS NK cell line scFv-DAP12 TM+IC Glioblastoma / Müller et al. (90)
EGFRvIII KHYG-1 NK cell line scFv-CD28 TM+IC-CD137-CD3ζ Glioblastoma / Murakami et al. (119)
EGFRvIII NK92 cell line scFv-CD28 TM+IC-CD3ζ Glioblastoma / Han et al. (120)
HER2 NK92 cell line scFv-CD3 TM+IC Glioblastoma / Alkins et al. (121)
HER2 NK92 cell line scFv-CD28 TM+IC-CD3ζ Glioblastoma / Zhang et al. (122)
HER2 NK92 cell line scFv-CD28-CD3ζ Glioblastoma I NCT03383978
HER2 NK92 cell line Unknown Glioblastoma I NCT03383978
MUC1 Unknown Unknown High Grade Glioma I/II NCT02839954
None PBMCs None High Grade Glioma I NCT04254419
None PBMCs None Glioma I NCT00909558
None Placenta None High Grade Glioma I NCT04489420